Post-marketing surveillance of LUTATHERA Injection (All Case Study)
Not Applicable
Suspended
- Conditions
- Somatostatin receptor-positive neuroendocrine tumors
- Registration Number
- JPRN-jRCT2031220065
- Lead Sponsor
- Maki Keiji
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
All patients who received LUTATHERA Injection
Exclusion Criteria
none
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method